Outpatient treatment of low‐risk neutropenic fever in cancer patients using oral moxifloxacin
Article 2005 en
Authors
GC
Georgios Chamilos
AB
Aristotle Bamias
EE
Eleni Efstathiou
Abstract
1 min read
The results of the current study demonstrated that moxifloxacin was a highly effective and safe regimen in the outpatient treatment of cancer patients with febrile neutropenia.
George Fountzilas, C. Papadimitriou, Gerasimos Aravantinos, C. Nicolaides, G. Stathopoulos, Dimitrios Bafaloukos, Haralabos P. Kalofonos, T. Ekonomopoulos, D. Skarlos, Nicholas Pavlidis, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.